Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02351505
Title Selinexor in Treating Patients With Relapsed Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Erin Bertino
Indications

lung small cell carcinoma

Therapies

Selinexor

Age Groups: adult
Covered Countries USA


No variant requirements are available.